Michael Gallagher

1.6k citations

30 papers · 941 indexed · h-index 16

Impact in

Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Psychiatry and Mental health top 10%
- Fibromyalgia and Chronic Fatigue Syndrome Research

Papers in

Cancer Research 13
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 5
- Cancer Genomics and Diagnostics 4
Oncology 11
- Cancer Cells and Metastasis 8

Co-authors: John O’Leary Brendan Ffrench Claudia Gasch Kelly Thomas Monica Tsang Phillip K. Peterson Chun C. Chao Edward N. Janoff
Journals: American Journal of Obstetrics and Gynecology (2 papers)Journal of Ovarian Research (2 papers)Oncotarget (2 papers)Molecular Cancer (2 papers)SLAS DISCOVERY (1 paper)
Partner nations: Ireland United States Australia

In The Last Decade

Michael Gallagher

30 papers receiving 913 citations

Peers

Countries citing papers authored by Michael Gallagher

Since Specialization

Citations

This map shows the geographic impact of Michael Gallagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gallagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gallagher more than expected).

Fields of papers citing papers by Michael Gallagher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Gallagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gallagher. The network helps show where Michael Gallagher may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael Gallagher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Gallagher Line = papers co-authored together Michael Gallagher links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Combat‐related peripheral nerve injuries Muscle & Nerve ·Andreas Schlattmann, Abby Ayoola, Michael Gallagher, Matthew E. Miller, Ross C. Puffer	2024	1
2	Ex vivo expansion of circulating tumour cells (CTCs) Scientific Reports ·Bashir M. Mohamed, Mark P. Ward, Mark Bates, Cathy Spillane, Josefina Fernández Guadaño, Cara Martin, Michael Gallagher, Alexandre Teixeira Borges, Lucy Norris, John Kennedy, Feras Abu Saadeh, Noreen Gleeson, Doug A. Brooks, Robert D. Brooks, Stavros Selemidis, Sharon O’Toole, John O’Leary	2023	10
3	Circulating tumour cell enumeration does not correlate with Miller–Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy Breast Cancer Research and Treatment ·Sharon O’Toole, Cathy Spillane, Yanmei Huang, Srisom Suwanwong, Brendan Ffrench, Bashir M. Mohamed, Mark P. Ward, Michael Gallagher, Josefina Fernández Guadaño, Cathal Ó’Brien, Christine Reed, J. C. Machado, Cara Martin, 林树雄, Elizabeth Connolly, Sarah A. McGarrigle, John Kennedy, John O’Leary	2020	8
4	The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancer PLoS ONE ·Mark Bates, Cathy Spillane, Michael Gallagher, Amanda McCann, Cara Martin, Gordon Blackshields, Helen Keegan, Luke Gubbins, Robert D. Brooks, Doug A. Brooks, Stavros Selemidis, Sharon O’Toole, John O’Leary	2020	11
5	Exploring the Diagnostic Potential of Immune Biomarker Co-expression in Gulf War Illness Methods in molecular biology ·Gordon Broderick, Mary A Fletcher, Michael Gallagher, Zachary Barnes, Suzanne D. Vernon, Nancy G. Klimas	2018	8
6	Catching moving targets: cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention Molecular Cancer ·Claudia Gasch, Brendan Ffrench, John O’Leary, Michael Gallagher	2017	71
7	CD10−/ALDH− cells are the sole cisplatin-resistant component of a novel ovarian cancer stem cell hierarchy Cell Death and Disease ·Brendan Ffrench, Claudia Gasch, Karsten Hokamp, Cathy Spillane, Gordon Blackshields, Pharel Njessi, Mark Bates, Бороздин Аркадий Николаевич, Paula Ivanir Schimites, Sérgio D. Marinho, Brendan Doyle, Dearbhaile M. O’Donnell, Noreen Gleeson, Bryan T. Hennessy, Britta Stordal, Ciarán Ó’Riain, H. Lambkin, Sharon O’Toole, John O’Leary, Michael Gallagher	2017	14
8	Enhanced regulation of cell cycle and suppression of osteoblast differentiation molecular signatures by prostate cancer stem-like holoclones Journal of Clinical Pathology ·Michael Gallagher, Cong Pei, Cathy Spillane, Brendan Ffrench, C. D'Achille, Chen Weiwei, Paul Smyth, Cara Martin, Orla Sheils, R. William G. Watson, John O’Leary	2015	4
9	Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer BMC Cancer ·Aninda Swarnaker, Sharon O’Toole, Cathy Spillane, Cara Martin, Michael Gallagher, Britta Stordal, Gordon Blackshields, Orla Sheils, John O’Leary	2015	40
10	An integrated analysis of the SOX2 microRNA response program in human pluripotent and nullipotent stem cell lines BMC Genomics ·Sebastian Vencken, Praveen Sethupathy, Gordon Blackshields, Cathy Spillane, Achim Keune, Orla Sheils, Michael Gallagher, John O’Leary	2014	15
11	Suppression of cancer stemness p21-regulating mRNA and microRNA signatures in recurrent ovarian cancer patient samples Journal of Ovarian Research ·Michael Gallagher, Cynthia Heffron, Alexandros Laios, Sharon O’Toole, Brendan Ffrench, Estela Uy Clemente, Richard Flavin, Achim Keune, Cathy Spillane, Cara Martin, Orla Sheils, John O’Leary	2012	10
12	Exploring the Diagnostic Potential of Immune Biomarker Coexpression in Gulf War Illness Methods in molecular biology ·Gordon Broderick, Mary A Fletcher, Michael Gallagher, Zachary Barnes, Suzanne D. Vernon, Nancy G. Klimas	2012	22
13	Low MAD2 expression levels associate with reduced progression‐free survival in patients with high‐grade serous epithelial ovarian cancer The Journal of Pathology ·Fiona Furlong, Patricia Fitzpatrick, Sharon O’Toole, 焦晓霞, Su Chiu-Hun, Aoife Maguire, Anthony O’Grady, Michael Gallagher, Maria Prencipe, G. Verhaak, Paul McGettigan, Donal J. Brennan, Orla Sheils, Cara Martin, Elaine W. Kay, John O’Leary, Amanda McCann	2011	68
14	Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients Journal of Ovarian Research ·Michael Gallagher, Richard Flavin, Achim Keune, Kauffmann Theilig Partner, Estela Uy Clemente, Cong Pei, Sebastian Vencken, Sharon O’Toole, Alexandros Laios, Yung Dong, Karen Denning, Jinghuan Li, Sinéad Aherne, C P POORE, Cara Martin, Orla Sheils, John O’Leary	2009	15
15	Atypical Chest Pain: Coronary, Aortic, and Pulmonary Vasculature Enhancement at Biphasic Single-Injection 64-Section CT Angiography Radiology ·Thomas G. Vrachliotis, Kostaki G. Bis, Amir Denti, Courtney Retter, M. Balasubramaniam, Michael Gallagher, Gilbert Raff, Michael A. Ross, Brian J. O’Neil, Eugene Konagaya	2007	74
16	Global mRNA analysis to determine a transcriptome profile of cancer stemness in a mouse model. PubMed ·Cynthia Heffron, Michael Gallagher, Simone M Guenther, Jon Sherlock, Alexia Guerra, Cara Martin, Orla Sheils, John O’Leary	2007	6
17	Randomized Phase II Trial of High-Dose Melatonin and Radiation Therapy for RPA Class 2 Patients With Brain Metastases (RTOG 0119) International Journal of Radiation OncologyBiologyPhysics ·Lawrence Berk, Brian Berkey, Tyvin A. Rich, William J.M. Hrushesky, David E. Blask, Michael Gallagher, Mahesh Kudrimoti, Ronald C. McGarry, John H. Suh, Minesh P. Mehta	2007	41
18	APC Gene Expression in Gastric Carcinoma: An Immunohistochemical Study Applied immunohistochemistry & molecular morphology ·(unknown), David M. Butler, Michael Gallagher, Yang Pei-zhi, Xin Yan, M. Leader, E. Kay	2002	10
19	Polyreactive antigen-binding B cells are the predominant cell type in the newborn B cell repertoire European Journal of Immunology ·Zhi Jian Chen, Carl J. Wheeler, Wei Shi, Ava J. Wu, Cheryl Yarboro, Michael Gallagher, Abner Louis Notkins	1998	67
20	Detection of adrenomedullin, a hypotensive peptide, in amniotic fluid and fetal membranes American Journal of Obstetrics and Gynecology ·Charles J. Macri, Alfredo Martı́nez, Terry W. Moody, Karen Gray, Mae-Jean Miller, Michael Gallagher, Frank Cuttitta	1996	66

About Michael Gallagher

Michael Gallagher is a scholar working on Cancer Research, Oncology, Rehabilitation, Cell Biology and Occupational Therapy, having authored 30 papers that have together received 941 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (8 papers), MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (5 papers), Cancer Genomics and Diagnostics (4 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers), Epigenetics and DNA Methylation (3 papers), Microtubule and mitosis dynamics (3 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Cancer Research (197 citations), Psychiatry and Mental health (159 citations), Behavioral Neuroscience (32 citations), Oncology (232 citations) and Molecular Biology (388 citations). Michael Gallagher has collaborated with scholars based in Ireland, United States and Australia. Frequent co-authors include John O’Leary, Brendan Ffrench, Claudia Gasch, Kelly Thomas, Monica Tsang, Phillip K. Peterson, Chun C. Chao, Edward N. Janoff, Sharon O’Toole and Orla Sheils. Their work appears in journals such as American Journal of Obstetrics and Gynecology, Journal of Ovarian Research, Oncotarget, Molecular Cancer and SLAS DISCOVERY.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact